Swiss make breakthrough in spinal research
Novartis has begun clinical trials on humans with acute spinal injuries after Swiss scientists successfully re-grew nerve fibres in monkeys’ damaged spinal cords.
It follows extensive research into spinal cord Regeneration at the universities of Zurich and Fribourg, a report on which was published this week in Nature Medicine. Continue Reading »





